Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -13.15% is 81% above its 5-year average of -70.92%, near the high end of its 5-year range (-177.51%–-4.86%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.25% above its 12-month average of -15.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -13.15%.
RETURN ON INVESTED CAPITAL (ROIC)
-13.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-15.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-48.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-70.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.25%
CURRENT VS 3Y AVG
+72.87%
CURRENT VS 5Y AVG
+81.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.43%
median of 512 covered companies
CURRENT VS SECTOR MEDIAN
+55.30%
vs the sector median at left
Bright Minds Biosciences Inc.
Market Cap
$487.55M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-15.71%
3Y Avg
-48.49%
5Y Avg
-70.92%
Market Cap
$483.66M
Return on Invested Capital (ROIC)
-1.08%
TTM Avg
-7.18%
3Y Avg
-14.01%
5Y Avg
-19.76%
Market Cap
$479.42M
Return on Invested Capital (ROIC)
-15.54%
TTM Avg
-22.63%
3Y Avg
-32.48%
5Y Avg
-46.23%
Market Cap
$475.84M
Return on Invested Capital (ROIC)
-2.19%
TTM Avg
-24.50%
3Y Avg
-28.59%
5Y Avg
-24.45%
Market Cap
$491.93M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$473.72M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$463.63M
Return on Invested Capital (ROIC)
6.95%
TTM Avg
6.49%
3Y Avg
4.50%
5Y Avg
4.55%
Market Cap
$512.56M
Return on Invested Capital (ROIC)
-34.79%
TTM Avg
-53.61%
3Y Avg
-51.25%
5Y Avg
-40.96%
Market Cap
$462.36M
Return on Invested Capital (ROIC)
-27.22%
TTM Avg
-25.30%
3Y Avg
-27.88%
5Y Avg
-30.72%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $487.55M | -13.15% | -15.71% | -48.49% | -70.92% |
| Cerus Corporation (CERS)vs › | $483.66M | -1.08% | -7.18% | -14.01% | -19.76% |
| Evolus, Inc. (EOLS)vs › | $479.42M | -15.54% | -22.63% | -32.48% | -46.23% |
| Arvinas, Inc. (ARVN)vs › | $475.84M | -2.19% | -24.50% | -28.59% | -24.45% |
| NeoGenomics, Inc. (NEO)vs › | $491.93M | -5.29% | -5.58% | -6.88% | -5.95% |
| NRC Health (NRC)vs › | $473.72M | 8.75% | 20.32% | 26.86% | 29.17% |
| Kamada Ltd. (KMDA)vs › | $463.63M | 6.95% | 6.49% | 4.50% | 4.55% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $512.56M | -34.79% | -53.61% | -51.25% | -40.96% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $462.36M | -27.22% | -25.30% | -27.88% | -30.72% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $459.09M | -100.87% | -63.16% | -52.79% | -48.48% |
ROIC
-13.2%
ROE
-8.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -13.15% |
| 2026-03-31 | -10.25% |
| 2025-12-31 | -21.29% |
| 2025-09-30 | -16.88% |
| 2025-06-30 | -16.96% |
| 2025-03-31 | -9.98% |
| 2024-12-31 | -4.86% |
| 2024-09-30 | -51.15% |
| 2024-06-30 | -59.72% |
| 2024-03-31 | -93.12% |
| 2023-12-31 | -110.32% |
| 2023-09-30 | -111.90% |
| 2023-06-30 | -110.80% |
| 2023-03-31 | -112.21% |
| 2022-12-31 | -116.06% |
| 2022-09-30 | -149.59% |
| 2022-06-30 | -177.51% |
| 2022-03-31 | -144.92% |
| 2021-12-31 | -86.01% |
| 2021-09-30 | -45.12% |
| 2021-06-30 | -27.59% |
| 2021-03-31 | -9.93% |
| 2020-12-31 | -49.80% |
| 2020-09-30 | -65.07% |
